DS-Connect® Challenge Impact: A Look at the Map

Categories: Blog, Why Support Research?

At LuMind Foundation, we bring light to the science of Down syndrome cognition research. Thanks to to the amazing support for LuMind Foundation’s DS-Connect® Challenge, hundreds of you brought a glow to the DS-Connect® map! On the map of the major metropolitan areas where aggregate, de-identified information is displayed, six areas now glow bright red. A big shout-out …

Read More

Update on Transition Clinical Trial: ELND005

Categories: Blog, Clinical Trials, Ds Research, News

Transition Therapeutics Inc. (Elan) announced the results of a clinical study of drug candidate ELND005 in young adults with Down syndrome. The study focuses on neuropsychiatric symptoms associated with Alzheimer’s disease and cognition in people with Ds. In our September 2013 Newsflash, LuMind Foundation’s Chief Scientific Officer Dr. Harpold explained the ELND005 study. Essentially, ELND005 …

Read More